David Zeferino D'Azevedo Cristina
Chief Executive Officer at Acellera Therapeutics Lda.
David Zeferino D'Azevedo Cristina active positions
| Companies | Position | Start | End |
|---|---|---|---|
Acellera Therapeutics Lda.
 Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Chief Executive Officer | 2010-06-30 | - |
| Founder | 2010-06-30 | - | |
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Director/Board Member | - | - |
Career history of David Zeferino D'Azevedo Cristina
Former positions of David Zeferino D'Azevedo Cristina
| Companies | Position | Start | End |
|---|---|---|---|
Portugal Capital Ventures SCR SA
 Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Consultant / Advisor | 2015-02-28 | 2017-10-30 |
Statistics
International
| Portugal | 4 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
| Consultant / Advisor | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Health Technology |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Finance |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
